Literature DB >> 321415

Interaction between rifampicin and trimethoprim in vitro and in experimental infections.

V Arioli, M Berti, G Carniti, E Rossi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 321415     DOI： 10.1093/jac/3.1.87

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Evidence that rifampicin can be used safely for non-tuberculous diseases.

Authors:  G Acocella; W Brumfitt; J M Hamilton-Miller
Journal:  Thorax       Date:  1980-10       Impact factor: 9.139

2.  Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.

Authors:  G E Stein; D Gurwith; M Gurwith
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

3.  Trimethoprim-rifampin, a new combination agent: efficacy in localized urinary infection and influence on microflora.

Authors:  A M Bourgault; K R Forward; A R Ronald; G K Harding; M Thomson; G Grey
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

4.  Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.

Authors:  B P Goldstein; I F Ripamonti; G Bolzoni; G Carniti; V Arioli
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

5.  Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices.

Authors:  G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.